Dissecting structure-function of 3-O-sulfated heparin and engineered heparan sulfates

Richard Karlsson, Pradeep Chopra, Apoorva Joshi, Zhang Yang, Sergey Y. Vakhrushev, Thomas Mandel Clausen, Chelsea D. Painter, Gergo P. Szekeres, Yen Hsi Chen, Daniel R. Sandoval, Lars Hansen, Jeffrey D. Esko, Kevin Pagel, Douglas P. Dyer, Jeremy E. Turnbull, Henrik Clausen, Geert Jan Boons, Rebecca L. Miller*

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

29 Citations (Scopus)
36 Downloads (Pure)

Abstract

Heparan sulfate (HS) polysaccharides are master regulators of diverse biological processes via sulfated motifs that can recruit specific proteins. 3-O-sulfation of HS/heparin is crucial for anticoagulant activity, but despite emerging evidence for roles in many other functions, a lack of tools for deciphering structure-function relationships has hampered advances. Here, we describe an approach integrating synthesis of 3-O-sulfated standards, comprehensive HS disaccharide profiling, and cell engineering to address this deficiency. Its application revealed previously unseen differences in 3-O-sulfated profiles of clinical heparins and 3-O-sulfotransferase (HS3ST)-specific variations in cell surface HS profiles. The latter correlated with functional differences in anticoagulant activity and binding to platelet factor 4 (PF4), which underlies heparin-induced thrombocytopenia, a known side effect of heparin. Unexpectedly, cells expressing the HS3ST4 isoenzyme generated HS with potent anticoagulant activity but weak PF4 binding. The data provide new insights into 3-O-sulfate structure-function and demonstrate proof of concept for tailored cell-based synthesis of next-generation heparins.

Original languageEnglish
Article numbereabl6026
JournalScience Advances
Volume7
Issue number52
ISSN2375-2548
DOIs
Publication statusPublished - 2021

Bibliographical note

Publisher Copyright:
Copyright © 2021 The Authors, some rights reserved.

Cite this